Docket nos. 89-243 | End date 1990 | |
Citations 496 U.S. 661 (more)110 S. Ct. 2683; 110 L. Ed. 2d 605; 1990 U.S. LEXIS 3184; 58 U.S.L.W. 4838; 15 U.S.P.Q.2D (BNA) 1121 Prior history Certiorari to the Circuit Court of Appeal for the Federal Circuit. Subsequent history Rehearing Denied, August 14, 1990, Reported at 1990 U.S. LEXIS 3730. Majority Scalia, joined by Rehnquist, Brennan, Marshall, Blackmun, Stevens People also search for Merck KGaA v. Integra Lifesciences I, Ltd. | ||
Eli Lilly and Company v. Medtronic, Inc., 496 U.S. 661 (1990), is a United States Supreme Court case related to patent infringement in the Medical device industry. It held that 35 U.S.C. ยง 271(e)(1) of United States patent law exempted premarketing activity conducted to gain approval of a device under the Federal Food, Drug, and Cosmetic Act from a finding of infringement.
References
Eli Lilly & Co. v. Medtronic, Inc. Wikipedia(Text) CC BY-SA